183 related articles for article (PubMed ID: 31661534)
1. Common variants in glyoxalase I do not increase chronic pancreatitis risk.
Kaune T; Hollenbach M; Keil B; Chen JM; Masson E; Becker C; Damm M; Ruffert C; Grützmann R; Hoffmeister A; Te Morsche RHM; Cavestro GM; Zuppardo RA; Saftoiu A; Malecka-Panas E; Głuszek S; Bugert P; Lerch MM; Weiss FU; Zou WB; Liao Z; Hegyi P; Drenth JP; Riedel J; Férec C; Scholz M; Kirsten H; Tóth A; Ewers M; Witt H; Griesmann H; Michl P; Rosendahl J
PLoS One; 2019; 14(10):e0222927. PubMed ID: 31661534
[TBL] [Abstract][Full Text] [Related]
2. The GLO1 C332 (Ala111) allele confers autism vulnerability: family-based genetic association and functional correlates.
Gabriele S; Lombardi F; Sacco R; Napolioni V; Altieri L; Tirindelli MC; Gregorj C; Bravaccio C; Rousseau F; Persico AM
J Psychiatr Res; 2014 Dec; 59():108-16. PubMed ID: 25201284
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study.
Derikx MH; Kovacs P; Scholz M; Masson E; Chen JM; Ruffert C; Lichtner P; Te Morsche RH; Cavestro GM; Férec C; Drenth JP; Witt H; Rosendahl J;
Gut; 2015 Sep; 64(9):1426-33. PubMed ID: 25253127
[TBL] [Abstract][Full Text] [Related]
4. GLO1 gene polymorphisms and their association with retinitis pigmentosa: a case-control study in a Sicilian population.
Donato L; Scimone C; Nicocia G; Denaro L; Robledo R; Sidoti A; D'Angelo R
Mol Biol Rep; 2018 Oct; 45(5):1349-1355. PubMed ID: 30099685
[TBL] [Abstract][Full Text] [Related]
5. Association between
Zeng Q; Yang T; Wei W; Zou D; Wei Y; Han F; He J; Huang J; Guo R
Front Endocrinol (Lausanne); 2023; 14():1235581. PubMed ID: 38027126
[TBL] [Abstract][Full Text] [Related]
6. The genetic polymorphisms and activity of glyoxalase 1 as a risk factor for acute coronary syndrome in South Indians with type 2 diabetes mellitus.
Bora S; Adole PS; Vinod KV; Pillai AA; Ahmed S
Gene; 2023 Nov; 885():147701. PubMed ID: 37572800
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of advanced glycation end products and their receptors sRAGE and Galectin-3 in chronic pancreatitis.
Böhme R; Becker C; Keil B; Damm M; Rasch S; Beer S; Schneider R; Kovacs P; Bugert P; Riedel J; Griesmann H; Ruffert C; Kaune T; Michl P; Hesselbarth N; Rosendahl J
Pancreatology; 2020 Mar; 20(2):187-192. PubMed ID: 31870801
[TBL] [Abstract][Full Text] [Related]
8. Identification of glyoxalase 1 polymorphisms associated with enzyme activity.
Peculis R; Konrade I; Skapare E; Fridmanis D; Nikitina-Zake L; Lejnieks A; Pirags V; Dambrova M; Klovins J
Gene; 2013 Feb; 515(1):140-3. PubMed ID: 23201419
[TBL] [Abstract][Full Text] [Related]
9. Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity--implications for autism.
Barua M; Jenkins EC; Chen W; Kuizon S; Pullarkat RK; Junaid MA
Autism Res; 2011 Aug; 4(4):262-70. PubMed ID: 21491613
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies.
Engelen L; Ferreira I; Brouwers O; Henry RM; Dekker JM; Nijpels G; Heine RJ; van Greevenbroek MM; van der Kallen CJ; Blaak EE; Feskens EJ; ten Cate H; Stehouwer CD; Schalkwijk CG
J Hypertens; 2009 Jul; 27(7):1399-403. PubMed ID: 19412133
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.
Chocholatý M; Jáchymová M; Schmidt M; Havlová K; Křepelová A; Zima T; Babjuk M; Kalousová M
Tumour Biol; 2015 Mar; 36(3):2121-6. PubMed ID: 25407489
[TBL] [Abstract][Full Text] [Related]
12. Role of glyoxalase I gene polymorphisms in late-onset epilepsy and drug-resistant epilepsy.
Tao H; Si L; Zhou X; Liu Z; Ma Z; Zhou H; Zhong W; Cui L; Zhang S; Li Y; Ma G; Zhao J; Huang W; Yao L; Xu Z; Zhao B; Li K
J Neurol Sci; 2016 Apr; 363():200-6. PubMed ID: 27000251
[TBL] [Abstract][Full Text] [Related]
13. Role of the Common
Herzig AF; Génin E; Cooper DN; Masson E; Férec C; Chen JM
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33202925
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation.
Xue M; Rabbani N; Momiji H; Imbasi P; Anwar MM; Kitteringham N; Park BK; Souma T; Moriguchi T; Yamamoto M; Thornalley PJ
Biochem J; 2012 Apr; 443(1):213-22. PubMed ID: 22188542
[TBL] [Abstract][Full Text] [Related]
15. Weak association of glyoxalase 1 (GLO1) variants with autism spectrum disorder.
Kovač J; Podkrajšek KT; Lukšič MM; Battelino T
Eur Child Adolesc Psychiatry; 2015 Jan; 24(1):75-82. PubMed ID: 24671236
[TBL] [Abstract][Full Text] [Related]
16. Analysis of GPRC6A variants in different pancreatitis etiologies.
Kaune T; Ruffert C; Hesselbarth N; Damm M; Krug S; Cardinal von Widdern J; Masson E; Chen JM; Rebours V; Buscail L; Férec C; Grützmann R; Te Morsche RHM; Drenth JP; Cavestro GM; Zuppardo RA; Saftoiu A; Malecka-Panas E; Głuszek S; Bugert P; Lerch MM; Sendler M; Weiss FU; Zou WB; Deng SJ; Liao Z; Scholz M; Kirsten H; Hegyi P; Witt H; Michl P; Griesmann H; Rosendahl J
Pancreatology; 2020 Oct; 20(7):1262-1267. PubMed ID: 32859544
[TBL] [Abstract][Full Text] [Related]
17. No association between common variants in glyoxalase 1 and autism spectrum disorders.
Rehnström K; Ylisaukko-Oja T; Vanhala R; von Wendt L; Peltonen L; Hovatta I
Am J Med Genet B Neuropsychiatr Genet; 2008 Jan; 147B(1):124-7. PubMed ID: 17722011
[TBL] [Abstract][Full Text] [Related]
18. Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction.
Blackburn NJR; Vulesevic B; McNeill B; Cimenci CE; Ahmadi A; Gonzalez-Gomez M; Ostojic A; Zhong Z; Brownlee M; Beisswenger PJ; Milne RW; Suuronen EJ
Basic Res Cardiol; 2017 Sep; 112(5):57. PubMed ID: 28864889
[TBL] [Abstract][Full Text] [Related]
19. C332C genotype of glyoxalase 1 and its association with late diabetic complications.
Groener JB; Reismann P; Fleming T; Kalscheuer H; Lehnhoff D; Hamann A; Roser P; Bierhaus A; Nawroth PP; Rudofsky G
Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):436-9. PubMed ID: 23775136
[TBL] [Abstract][Full Text] [Related]
20. Loss of Glyoxalase 1 Induces Compensatory Mechanism to Achieve Dicarbonyl Detoxification in Mammalian Schwann Cells.
Morgenstern J; Fleming T; Schumacher D; Eckstein V; Freichel M; Herzig S; Nawroth P
J Biol Chem; 2017 Feb; 292(8):3224-3238. PubMed ID: 27956549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
